BC Platforms AG, one of the healthcare industry’s largest data management and analytics companies, has launched a new technology platform that features artificial intelligence as its core component. This comes at a time when AI is being applied across drug discovery in order to help researchers analyse large datasets and identify potential drug targets. The Switzerland-based company says that its new technology takes AI one step further by linking drug discovery and development data to real-world evidence.
